financetom
Business
financetom
/
Business
/
Jade Biosciences Says to Raise $45 Million via Private Placement of 3.2 Million Shares
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jade Biosciences Says to Raise $45 Million via Private Placement of 3.2 Million Shares
Mar 10, 2026 10:27 PM

07:59 AM EST, 12/15/2025 (MT Newswires) -- Jade Biosciences ( JBIO ) said Monday it has reached an agreement with BB Biotech to sell 3.2 million common shares through a private placement, raising $45 million in gross proceeds.

Shares will be sold at $14 apiece, Jade said, adding that the private placement is expected to close on Tuesday.

The company said it intends to use net proceeds to fund research and development, general corporate expenses, and working capital needs.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Global Water Files Settlement Deal in Farmers Water Rate Case
Global Water Files Settlement Deal in Farmers Water Rate Case
Feb 4, 2025
10:58 AM EST, 02/04/2025 (MT Newswires) -- Global Water Resources ( GWRS ) said Tuesday it has reached a unanimous settlement agreement over the general rate case application of its Global Water - Farmers Water Company unit. The company said the settlement agreement was filed with the Arizona Corporation Commission last month, with a hearing on the agreement scheduled to...
Tornado Infrastructure Equipment Up 3% As Launches Financing Arm, Provides Q4 Business Update
Tornado Infrastructure Equipment Up 3% As Launches Financing Arm, Provides Q4 Business Update
Feb 4, 2025
10:58 AM EST, 02/04/2025 (MT Newswires) -- Tornado Global Hydrovacs (TGH.V), involved in the vacuum truck industry, was at last look up 3% on Tuesday after launching Tornado Equipment Finance, a dedicated financing arm to provide financing solutions to support to customers in Canada. The company in a statement said it expects the new initiative to generate a steady additional...
What's Going On With Aclarion Stock Tuesday?
What's Going On With Aclarion Stock Tuesday?
Feb 4, 2025
Aclarion, Inc. ( ACON ) stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its diagnostic tool, Nociscan. What To Know: The company has raised approximately $20 million in gross proceeds since the start of 2025, which will fully fund the clinical trial. The trial aims to test Nociscan's ability to...
United Therapeutics Completes Patient Enrollment for Another Trial of Idiopathic Pulmonary Fibrosis Treatment
United Therapeutics Completes Patient Enrollment for Another Trial of Idiopathic Pulmonary Fibrosis Treatment
Feb 4, 2025
10:59 AM EST, 02/04/2025 (MT Newswires) -- United Therapeutics ( UTHR ) said Tuesday that a phase 3 study evaluating the use of nebulized Tyvaso to treat idiopathic pulmonary fibrosis, of IPF, has reached full enrollment. The 598-patient Teton 1 study is part of three-study clinical trial program assessing the use of inhaled treprostinil in IPF and a similar condition...
Copyright 2023-2026 - www.financetom.com All Rights Reserved